A pioneer in immuno-modulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers.
Looking for a particular Immunohelix employee's phone or email?
The Immunohelix annual revenue was $7 million in 2026.
Tadahiro Matsudaira is the VP of Development of Immunohelix.
1 people are employed at Immunohelix.
Immunohelix is based in Burlingame, California.
The NAICS codes for Immunohelix are [32, 325, 3254, 32541].
The SIC codes for Immunohelix are [283, 28].